Company intelligence / Profile preview
IBSS Biomed S.A.
Kraków, Lesser Poland Voivodeship, Polandbiomed.pl ↗
- Ownership
- Private
- Employees
- ~105
- Development stage
- Commercial
01
Overview
The company produces commercialized vaccines with proven effectiveness in clinical studies, oral rehydration solutions for dehydration management, probiotics for urogenital health and other indications. It claims to have the world’s only vaccine against Pseudomonas aeruginosa. Products are sold in Europe, Asia, Africa; ongoing R&D activities.[1][2][3]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Bacterial vaccines (specific and non-specific)Probiotics (medicinal and food products)Biological drugs[2][3][4]
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on IBSS Biomed S.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IBSS Biomed S.A..